Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States, December 2021–June 2022 | MM
Ruth Link-Gelles, PhD1; Matthew E. Levy, PhD2; Manjusha Gaglani, MBBS3,4; Stephanie A. Irving, MHS5; Melissa Stockwell, MD6,7,8; Kristin Dascomb, MD,...
